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Background: Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a diverse group of
biologically active bacterial molecules. Due to the conserved genomic arrangement of many of the genes involved
in their synthesis, these secondary metabolite biosynthetic pathways can be predicted from genome sequence data.
To date, however, despite the myriad of sequenced genomes covering many branches of the bacterial phylogenetic
tree, such an analysis for a broader group of bacteria like anaerobes has not been attempted.
Results: We investigated a collection of 211 complete and published genomes, focusing on anaerobic bacteria,
whose potential to encode RiPPs is relatively unknown. We showed that the presence of RiPP-genes is widespread
among anaerobic representatives of the phyla Actinobacteria, Proteobacteria and Firmicutes and that, collectively,
anaerobes possess the ability to synthesize a broad variety of different RiPP classes. More than 25% of anaerobes
are capable of producing RiPPs either alone or in conjunction with other secondary metabolites, such as polyketides
or non-ribosomal peptides.
Conclusion: Amongst the analyzed genomes, several gene clusters encode uncharacterized RiPPs, whilst others
show similarity with known RiPPs. These include a number of potential class II lanthipeptides; head-to-tail cyclized
peptides and lactococcin 972-like RiPP. This study presents further evidence in support of anaerobic bacteria as an
untapped natural products reservoir.
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The increasing number of multiresistant bacteria pose a
constant challenge for medicine and dictate the necessity
of developing new antimicrobial compounds to treat life-
threatening infections. Ribosomally synthesized and post-
translationally modified peptides (RiPPs) are a promising
addition to antibiotics biosynthesized via polyketide or
non-ribosomal pathways. As antimicrobial agents this
group of compounds often possess a narrow activity
spectrum, most often targeting near relatives of the pro-
ducing organism, although some broader spectrum RiPPs
have been identified [1-3]. Their limited range of activity* Correspondence: christian.hertweck@hki-jena.de
1Leibniz Institute for Natural Product Research and Infection Biology HKI,
Beutenbergstr. 11a, Jena 07745, Germany
3Chair of Natural Product Chemistry, Friedrich Schiller University, Jena 07743,
Germany
Full list of author information is available at the end of the article
© 2014 Letzel et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.makes RiPPs potential targets for clinical applications as
they can avoid the off-target effects seen with broad
spectrum antibiotic agents, which can disturb the normal
flora and open the door to undesired secondary infections
by resistant organisms [3]. Although their target organ-
isms may be highly specific, RiPPs have been shown to
interrupt a variety of cellular processes, including the dis-
ruption of DNA, RNA or protein biosynthesis, although
they commonly form pores in cell membranes by either
targeting lipid II, a cell wall building block, or by direct
pore formation via insertion into the cell wall [3]. As the
targets of these compounds are conserved amongst many
bacteria and are not subject to heavy modification, the po-
tential for the development of resistance against RiPPs is
significantly diminished [3,4].
Despite the fact that RiPPs cover a diverse range of
structural classes, they all follow a simple biosynthetic
logic: a precursor peptide consisting of an N-terminaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by a single gene is translated, the leader sequence is re-
moved by a series of transporters, peptidases or a combin-
ation of both, and the remaining active peptide moiety is
further processed by other enzymes, often encoded by
genes within close proximity to the precursor gene [1,2,5].
The genetic basis for the production of many RiPP
classes is well understood, and in most cases, gene con-
tent and structure is conserved amongst different arms
of the bacterial phylogenetic tree. As such, comparison
of well characterized biosynthetic genes or gene clusters
against new genome sequences can identify putative
RiPPs and in some cases, even the structure of the target
metabolite can be predicted [6]. This "genome mining"
approach allows for the discovery of potentially novel
natural products in a completely culture independent
fashion, with the potential to reduce the rediscovery rate
of known molecules. Furthermore, genome mining has
expanded the definition of exactly what constitutes a
secondary metabolite producer and has revealed that the
biosynthetic potential of many microorganisms has been
widely underestimated [7-9]. Amongst these newly iden-
tified producers lie the anaerobic bacteria, a group that
were believed to be incapable of producing secondary
metabolites, as life without oxygen was presumed to not
provide the required energy for the complex biosynthesis
of antibiotics [10]. These “neglected” bacteria include
those that are known to produce highly toxic peptides
(botulinum toxin, tetanus toxin), and more recently sev-
eral species have been identified as the source of novel
natural products [8,11-13]. An extensive investigation of
211 genomes of anaerobic bacteria for the presence of
polyketide synthase (PKS) or non-ribosomal peptide syn-
thetase (NRPS) encoding genes revealed a much larger po-
tential than previously suspected and many of these PKS
or NRPS loci appeared to be novel, with limited homology
to previously characterized gene clusters [8]. Furthermore,
it showed that certain genera have a predisposition to-
wards increased secondary metabolite potential (such as
members of the phyla Proteobacteria and Firmicutes) and
that the natural habitat of the organisms seems to play an
important role – isolates from environmental strains (soil,
mud) often contain up to three times more genes for sec-
ondary metabolite biosynthesis than all other habitats
combined. In particular, the clostridia were shown to be a
potential treasure trove of novel secondary metabolites,
which the isolation of the novel antibiotics closthioamide
and clostrubin have recently confirmed [13,14].
Despite the recent investigation of anaerobes for their po-
tential to produce polyketide or non-ribosomal peptide me-
tabolites [8], little is known about their ability to produce
RiPPs. As anaerobes have been shown to possess a wealth
of novel biosynthetic gene clusters, this suggests that there
is also the potential to identify novel RiPP genetic lociamongst these organisms. This may, in turn, lead to the dis-
covery of novel antimicrobial compounds to treat multi-
drug resistant infections. Here we present an in-depth in-
vestigation of RiPP-encoding genes within the genomes of
211 anaerobic bacteria. As the nomenclature for RiPPs was
redefined in 2013, with the support of many in the natural
products community, we have chosen to follow these rec-
ommendations here, and have placed a size limit of 10 kDa
for inclusion as a potential RiPP [1]. We have used a variety
of bioinformatic tools in our analysis, including anti-
SMASH [15,16], Bagel and bactibase database screening
[17,18], and BLAST searches to identify and predict the
presence of RiPP gene clusters. Here we have shown that
anaerobes have the potential to produce a variety of differ-
ent RiPPs and that there is tendency towards the presence
of RiPP biosynthetic gene clusters within those that already
possess genetic loci for other secondary metabolites.
Results and discussion
General features of anaerobe genomes with respect to
RiPPs
To survey the diversity of RiPPs we have undertaken a
bioinformatic investigation of 211 complete and published
anaerobe genomes for the presence of RiPP genes and
gene clusters. Of note is the fact that anaerobes are a po-
tential source of RiPPs, with >25% of currently sequenced
anaerobe genomes encoding at least one or more RiPP
classes (Table 1). It appears as though the RiPP biosyn-
thetic gene clusters are more likely to be found in strains
that possess other secondary metabolite biosynthetic gene
loci, with only 10.4% of analyzed genomes containing only
RiPP-encoding genes. However, these trends may only
be predictable for the phyla Firmicutes, Actinobacteria,
Bacteriodetes, Proteobacteria and Spirochaetes, which
comprise a sufficient number of genomes for a repre-
sentative analysis (Table 1, Figure 1). To what extent the
present results also represent a general trend for the other
phyla is difficult to estimate and more genomes of these
phyla are required. The combination of PKS/NRPS and
RiPPs appears to be limited to the phyla Actinobacteria,
Proteobacteria and Firmicutes, confirming previous re-
ports in aerobic organisms [1]. Notably, RiPP biosynthetic
gene clusters were not identified in any anaerobes from
the phylum Bacteriodetes, although aerobes from this
phylum have been shown to possess lanthipeptide gene
clusters [1]. In contrast to the situation with PKS/NRPS
gene clusters, which are absent in Spirochaetes genomes,
a small number of these organisms appear capable of pro-
ducing RiPPs (Table 1, Figure 1). As is the case with PKS/
NRPS biosynthetic gene clusters, of the sequenced ge-
nomes in our analysis, the Firmicutes appear to con-
tain the highest percentage of RiPP producers, with
approximately 75% of the Clostridium species ana-
lyzed being capable of producing PKS/NRPS or RiPPs.







Number of strains without
PKS/NRPS/RiPP
Number of strains both
PKS/NRPS and RiPP
Actinobacteria 33 3(9.1%) 3(9.1%) 21(63.6%) 6(18.2%)
Bacteroidetes 14 0 4(28.6%) 10(71.4%) 0
Chlorobi 1 0 0 1(100%) 0
Chloroflexi 6 2(33.3%) 0 4(66.7%) 0
Chrysiogenetes 1 0 0 1(100%) 0
Proteobacteria 24 1(4.2%) 11(45.8%) 9(37.5%) 3(12.5%)
Deferribacteres 4 0 0 4(100%) 0
Deinococcus-Thermus 1 0 0 1(100%) 0
Elusibacteria 1 0 1(100%) 0 0
Fibrobacteres 1 0 1(100%) 0 0
Firmicutes 83 11(13.3%) 8(9.6%) 36(43.4%) 28(33.7%)
Other 48 8(16.7%) 2(4.2%) 29 (60.4%) 9(18.7%)
Clostridium 35 3 (8.6%) 6(17.2%) 7(20.0%) 19(54.2%)
Fusobacteria 4 0 4(100%) 0 0
Spirochaetes 21 4(19.0%) 0 17(81.0%) 0
Synergistetes 3 0 0 3(100%) 0
Thermodesulfobacteria 1 0 0 1(100%) 0
Thermotogae 9 1(11.1%) 0 8(88.9%) 0
Verrucomicrobia 2 0 1(50%) 1(50%) 0
Not classified 2 0 1(50%) 1(50%) 0
Total 211 22(10.4%) 34(16.1%) 118(55.9%) 37(17.6%)
Letzel et al. BMC Genomics 2014, 15:983 Page 3 of 21
http://www.biomedcentral.com/1471-2164/15/983When it comes to the kind of RiPPs which are produced
by the respective strains lanthipeptides, sactipeptides and
linear azol(in)e-containing peptides (LAP) are the most
common types (each group of RiPPs is explained in fur-
ther detail below). LAP- and lactococcin-like genes areFigure 1 Potential of anaerobic bacteria for PKS/NRPS/RiPP productio
for secondary metabolite production; percentage of strains containing: no
PKS/NRPS (yellow); only RiPP (red) B Distribution of secondary metabolite con
production (no PKS/NRPS/RiPP genes (green); both PKS/NRPS and RiPP genes
are additionally divided into Clostridia and others.present predominantly in human pathogenic strains,
whilst strains from extreme environments tend to contain
DNA encoding head-to-tail cyclized peptides, as well as
lanthipeptides and sactipeptides (Table 2, Figure 2). Lasso
peptide biosynthetic loci appear to be mainly containedn and distribution among different phyla. A Distribution of genes
PKS/NRPS/RiPP genes (green); both PKS/NRPS and RiPP (blue); only
taining strains according to phyla and ability for secondary metabolite
(blue); only PKS/NRPS genes (yellow); only RiPP genes (red)). Firmicutes




























Firmicutes 12 14 11 1 5 5 2 6 56
Other 3 6 1 5 4 1 5 25








Total 15 16 15 2 7 8 10 8 81
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appear to follow a similar distribution. Proteobacteria pre-
dominantly contain lasso peptide gene clusters and these
are also more common in non-clostridia Firmicutes as
well as head-to-tail cyclized peptides (Table 2, Figure 2).Figure 2 Distribution of different RiPP biosynthetic gene clusters by h
(soil/mud) (red); extreme (green); other (purple); pathogenic (orange); non- paAlthough the focus here is on RiPP classes, several other
peptides with potential antimicrobial activity, such as hol-
ins, linocins or peptidases were also identified. However,
as their predicted size is much bigger than for the RiPPs,
they were excluded from the following analyses.abitat and pathogenicity. Animal (yellow); human (blue), environment
thogenic (black).
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The lanthipeptides are defined by the presence of the
non-proteinogenic amino acids lanthionine and 3-
methyllanthionine, which are crosslinked via a thioether
linkage at their β-carbon atoms [1,2,5,19,20]. The best-
known and characterized lanthipeptide is nisin, which wasFigure 3 Lichenicidin-like lanthipeptides. A Lichenicidin biosynthetic ge
gene clusters of C. botulinum H04402 065 and C. cellulovorans 743B; Numbers
each organism. B Comparison of lichenicidin peptide precursors (LicA1 and L
(H04402_00614 and H04402_00615) and C. cellulovorans 743B (Clocel_4229 an
leader sequence and core peptide (bold) C Formation of lanthionine (lan) and
residues to dehydroalanine (dha) / dehydrobutyrine (dhb) and subsequen
structure of lichenicidin α-subunit (Bliα).first reported in 1928, although its structure was only finally
elucidated in the 1970s [9,10]. The biosynthetic genes for
nisin had to wait until the late 1980s to be uncovered, and
since this time many lan biosynthetic loci have been identi-
fied. The synthesis of the unusual lanthionine and 3-
methyllanthionine residues occurs by dehydration of serinene cluster (lic) of B. licheniformis in comparison to putative lichenicidin
represent the locus tag for each gene within the genome sequence of
icA2) and the putative precursor peptides of C. botulinum H04402 065
d Clocel_4226); Glycine-Glycine motif indicates the cleavage site of
methyl-lanthionine (me-lan) moieties by dehydration of serine/threonine
t cyclization with a cysteine residue catalyzed by LanM D Amino acid
Letzel et al. BMC Genomics 2014, 15:983 Page 6 of 21
http://www.biomedcentral.com/1471-2164/15/983and threonine to dehydroalanine (dha) and dehydrobutyr-
ine (dhb), respectively, via phosphorylated intermediates,
which subsequently undergo a Michael-type addition
(cyclization) with a cysteine residue [1,5,19] (Figure 3).
Based on the enzymes that are responsible for the post-
translational modifications of the precursor peptides,
lanthipetides are divided into four different groups. Class I
lanthipeptides possess two distinct enzymes that carry out
the dehydration (LanB) and cyclization (LanC). Class II-IV
lanthipeptide are modified by multifunctional enzymes.
Class II lanthipeptides possess a bifunctional enzyme with a
N-terminal dehydratation (LanM- similar to LanB), and a
C-terminal cyclisation domain (similar LanC). In the case
of class III and IV lanthipeptides the modifications are car-
ried out by a specific tri functional enzymes LanKC and
LanL, respectively, which consist of an N-terminal
phosphoserine- or phosphothreoninelyase, a central kinase
and a C-terminal cyclisation domain [1,2,5,19]. Class III
lanthipeptides may also contain another non-proteinogenic
amino acid – labionin [21-23]. Labionin follows a similar
biosynthetic route to lanthionine, with cyclodehydration of
a cysteine and two serine residues, which then react in a
second Michael addition with another dehydroalanine
[21-23]. Due to the strong conservation of these modifying
enzymes they can be used for genome mining approaches
[24,25]. To date, characterized labionin-containing lanthi-
peptides are the labyrinthopeptide [21], erythreapeptin [26],Table 3 Detected putative lanthipeptide gene clusters
Phylum Lanthipep
Clostridium cellulovorans 743B, ATCC 35296 Firmicutes I
Clostridium kluyveri DSM 555 Firmicutes I
Bifidobacterium longum DJO10A Actino-bacteria II
Clostridium acetobutylicum ATCC 824 Fimicutes II
Clostridium acetobutylicum DSM 1731 Fimicutes II
Clostridium acetobutylicum EA 2018 Fimicutes II
Clostridium beijerinckii NCIMB 8052 Fimicutes II
Clostridium botulinum H04402 065 Fimicutes II
Clostridium cellulovorans 743B, ATCC 35296 Fimicutes II
II
Caldicellulosiruptor lactoaceticus 6A, DSM 9545 Fimicutes II
Caldicellulosiruptor bescii Z-1320, DSM 6725 Fimicutes II
Caldicellulosiruptor kristjanssonii 177R1B, DSM
12137
Fimicutes II
Bifidobacterium longum infantis JCM 1222,
ATCC 15697
Actino-bacteria IV
Propionibacterium acnes TypeIA2 P.acn17 Actino-bacteria IV
†Cluster shows similarities to characterized RiPP cluster; #Cluster was previously detavermipeptin [26], griseopeptin [26], catenulipeptin [27]
and NAI112 [23]. The activity spectrum of lanthipeptides
are mostly limited to Gram-positive bacteria and the mode
of action is often associated with the disturbance of cell wall
biosynthesis and pore formation [19], however, biosurfac-
tant lanthipeptides have also been identified [28,29].
In total 15 putative lanthipeptide biosynthetic gene
clusters were detected in the analysed bacterial genomes,
with class II lanthipeptides being the most common
(Table 3, Figures 3 and 4). The lanthipeptides were once
thought to be restricted to the Actinobacteria and Firmi-
cutes phyla and in terms of anaerobes, this also appears
to be the case [1]. Whilst some predicted lanthipeptide
biosynthetic gene clusters exhibit similarity to previously
characterized 2-component lanthipeptides, such as those
for lichenicidin VK21 (Bacillus licheniformis VK21) [30]
or lichenicidin (Bacillus licheniformis DSM 13 (ATCC
14580)), the remaining lanthipeptide gene clusters ap-
pear to be unique. The lichenicidins consist of two single
peptides which gain their full activity only in combin-
ation [30] and they are encoded by two different precur-
sor peptides as well as modified by two separate LanM
enzymes. The leader sequence is removed during the
transport out of the cell by the bifunctional enzyme
LanT (transporter with N-terminal protease) [31].
Similar to the lichenicidin gene cluster, two precursor





















ected by genome mining approaches.
Figure 4 Detected putative lanthipeptide gene clusters sorted by similar biosynthetic origin. Numbers represent the locus tag for each
gene within the genome sequence of each organism.
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ium botulinum H04402 065 and Clostridium cellulovorans
743B (Figure 3). The arrangement of the genes is different
in the respective clusters, but all the necessary core proteins
appear to be encoded. The lichenicidin gene cluster, how-
ever, possesses a number of genes for immunity, which
were not detected in the orthologous gene clusters in the
clostridia. However, the heterologous expression of the B.
licheniformis lichenicidin gene cluster in E. coli has shown
that the immunity genes are not necessary for production
of the lantibiotic, suggesting that the clostridial
lichenicidin-like gene clusters may also be capable of pro-
ducing an active lantibiotic [33]. It is also possible that the
immunity gene(s) are located elsewhere in the genome.BLAST analysis of the putative precursor peptides of Caldi-
cellulosiruptor bescii Z-1320 also showed similarities to
lichenicidin, but only one precursor peptide and one modi-
fying LanM protein are encoded in this cluster (Figure 4).
Sactipeptides
Sactipeptides or sactibiotics (sulphur to alpha-carbon anti-
biotic) are peptides in which a sulfur bridge is post-
translationally formed between a cysteine residue and the
α-carbon of another residue (Figure 5B & C), in contrast to
lanthipeptides where the sulfur bridge is installed via the β-
carbon [1,34]. The sulfur linkage is introduced via a special
radical SAM enzyme whose gene is co-localized in all sacti-
petide gene clusters and can be used for genome mining
Figure 5 Detected putative sactipeptides. A Thuricidin CD gene cluster (tm) of B. thuringiensis DPC 6431 and subtilosin A gene cluster (alb) of
B. subtilis 168 in comparison to detected putative sactipeptide gene clusters; Numbers represent the locus tag for each gene within the genome
sequence of each organism. B Amino acid structure of thuricin CD α-subunit (Trnα) C Characteristic sulfur bridge between a cysteine residue and
the α-carbon of another residue in sactipeptides.
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elucidated, all from Bacillus species, and include subtilosin
A (B. subtilis, hemolytic) [38,39], thuricin CD with its com-
ponents Trn-α and Trn-β (B. thuringiensis, anticlostridial)
[40], thurincin H (B. thuringiensis) [41] and the sporulation
killing factor (SKF) (B. subtilis) [42]. Approximately 0.5% of
the total protein content of anaerobic bacteria is repre-
sented by highly diverse radical SAM enzymes [43], and
using putative radical SAM enzymes as a means of identify-
ing sactipeptide loci returned a large number of enzymes
putatively involved in RiPP formation. A similar approach
was previously taken by Murphy et al., using the radical
SAM enzyme of the thuricin CD gene cluster as BLASTtemplate, which identified several thuricin CD-like biosyn-
thetic gene clusters, including several in anaerobic bacteria
[37].
In this study many putative sactipeptide like gene clus-
ters were obtained by using BAGEL database in a similar
fashion to those reported previously [37]. Screening of the
genes surrounding the encoded radical SAM proteins for
sactipeptide like accessory genes (such as transporters and
other proteins related to peptide maturation or secretion)
led to the exclusion of many putative gene clusters, with
those remaining listed in Table 4. Several of the gene clus-
ters showed similarities to thuricin CD (Figure 5A) as
mentioned above, however, the gene organization and
Table 4 Detected putative sactipeptide gene cluster
Phylum Locus tag of radical SAM Similar to† Reference#
Clostridium acetobutylicum DSM 1731 Firmicutes SMB_G0673
Clostridium acetobutylicum ATCC 824 Firmicutes CA_C0658
Clostridium acetobutylicum EA 2018 Firmicutes CEA_G0670
Clostridium cellulolyticum H10 Firmicutes Ccel_0328 thuricin [37]
Clostridium difficile 630 Firmicutes CD630_1620 thuricin [37]
Clostridium kluyveri DSM 555 Firmicutes CKL_0375
Clostridium lentocellum RHM5, DSM 5427 Firmicutes Clole_0089
Clostridium thermocellum ATCC 27405 Firmicutes Cthe_1695
Anaerococcus prevotii PC1, DSM 20548 Firmicutes Apre_1837 thuricin [37]
Ruminococcus albus 7, ATCC 27210 Firmicutes Rumal_0164
Syntrophobotulus glycolicus FIGlyR, DSM 8271 Firmicutes Sgly_1407
Thermoanaerobacter mathranii mathranii A3, DSM1142 Firmicutes Tmath_1976 thuricin [37]
Caldicellulosiruptor kristjanssonii 177R1B, DSM 12137 Firmicutes Calkr_0222 thuricin [37]
Halothermothrix orenii H 168 Firmicutes Hore_04320
Desulfobacca acetoxidans ASRB2, DSM 111069 δ- Proteobacteria Desac_0107
Thermosipho melanesiensis BI429 Thermotogae Tmel_0409
†Cluster shows similarities to characterized RiPP cluster; #Cluster was previously detected by genome mining approaches.
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pears that the number of radical SAM enzymes encoded
within a gene cluster correlates with the number of puta-
tive precursor peptides, except in case of Clostridium cel-
lulolyticum H10 where only one radical SAM per two
precursor peptides and Clostridium difficile 630 where
two radical SAM enzymes per precursor peptide are
encoded (Figure 5A).
Linear azol(in)e- containing peptides (LAP)
Many RiPPs are characterized by the presence of hetero-
cyclic functional groups, such as oxazoles and thiazoles.
One such group are the linear azol(in)e-containing pep-
tides (LAP), whose heterocycles are derived from the
cysteine, serine and threonine of a small precursor pep-
tide [1]. LAP comprise of four essential components: a
precursor peptide (known as ‘A’), and a heterotrimeric
enzyme complex consisting of a dehydrogenase (‘B’) and
cyclodehydratase (‘C’ and ‘D’). Biosynthetically, the first
step towards a LAP is the formation of an azoline-
heterocycle by the ‘C/D’ complex from serine or threo-
nine and a cysteine residue, followed by dehydrogenation
by ‘B’ leading to the corresponding azole (Figure 6C).
Known LAP include streptolysin S (Streptococcus pyo-
genes) [44], microcin B17 (Escherichia coli) [45], plantazoli-
cin (Bacillus amyloliquefaciens FBZ42) [46,47] (Figure 6D),
goadsporin (Streptomyces sp. TP- A0584) [48,49] and clos-
tridiolysin S (Clostridium botulinum) [50]. Despite the fact
that the ‘BCD’ enzyme complex exhibits rather low amino
acid identity between LAP loci, several studies have shown
that ‘BCD’ genes from one LAP biosynthetic gene clustercan complement different LAP synthesis pathways, with
the precursor peptide being converted into the active RiPP
[47,51]. As a result, these genes can be used for genome
mining approaches [24].
The detected LAP gene clusters are found exclusively in
the phyla of Firmicutes and Spirochaetes (Table 5). The
gene cluster for clostridiolysin S is conserved in almost all
Clostridium botulinum strains [50], except the strains
BKT015925 and E3 str. Alaska E43, where it is absent.
Like other LAP, the complete structure of clostridiolysin S
has not yet been solved, owing to the difficulty inherent in
the structure elucidation of heterocycles [50]. Several
strains within the genus Brachyspira (B. pilosicoli 95/1000,
B. intermedia PWS/A, B. murdochii 56–150 and B. hyody-
senteriae WA1) also share an identical gene cluster, with
only the precursor peptide of B. hyodysenteriae WA1 hav-
ing a slightly different amino acid sequence (Figure 6A
& B). The LAP gene cluster contained with the genome of
Thermoanaerobacter mathranii mathranii A3 has a differ-
ent gene organization.
Thiopeptides
Thiopeptides are characterized by a highly modified pep-
tide macrocycle including several thiozole rings, a six-
membered nitrogenous ring (either present as piperidine,
dehydropiperidine or pyridine) and a side chain contain-
ing multiple dehydrated amino acid residues [1,52,53].
The introduction of a second macrocycle increases the
complexity of these peptides and tryptophan-derived qui-
naldic acid or indolic acid residues are incorporated into
the peptide scaffold. As for LAP biosynthesis, the thiozole
Figure 6 Detected putative LAP gene cluster. A Gene cluster of plantazolicin (pzn) (B. amyloliquefeaciens FZB42), streptolysin S (sag) (S.
pyrogenes) and clostridiolysin S (clos) (C. botulinum ATCC 3502) in comparison to putative LAP gene clusters of B. intermedia, B. hyodysenteriae and
T. mathranii mathranii A3; Numbers represent the locus tag for each gene within the genome sequence of each organism. B Comparison of
precursor peptides of plantazolicin (PlnA), streptolysin S (SagA), clostridiolysin S (ClosA) with putative precursor peptides of B. intermedia, B.
hyodysenteriae, and T. mathranii mathranii A3; Cleavage site of leader and core peptide in bold. C Introduction of heterocycles in plantazolicin by
cyclodehydrogenase (PznC) and dehydrogenase (PznB) enzyme complex, X = S,O. D Chemical structure of plantazolicin.
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tion of serine and cysteine residues [1,52,53]. The central
nitrogen heterocycle is installed by a cycloaddition of two
dehydroalanines catalyzed by similar proteins found in
lanthipeptide biosynthesis (Figure 7C). Depending on the
oxidation state and substitution pattern of the central ni-
trogen heterocycle, thiopetides are classified into different
series (A-E) [1,52,53]. Thiomuracin A, isolated from a
Nonomuraea species with strong activity against S. aureus[54] (Figure 7D), represents a series D thiopeptide with a
tri-substituted pyridine ring as the central nitrogen het-
erocycle (Figure 7C). Besides the strong activity of many
thiopeptides against Gram-positive bacteria by interfering
with protein synthesis, some show additional antimalarial
or anticancer activities (thiostrepton A) [1,52,53].
Two putative thiopeptide gene clusters have been de-
tected in C. cellulovorans 743B and P. acnes KPA171202,
both most likely encoding a series D thiopeptide (Table 6).
Table 5 Detected LAP gene cluster
Phylum Locus Tag of dehydrogenase Similar to† Reference#
Clostridium botulinum A2 BoNT/A2 Kyoto-F Firmicutes CLM_0573 clostridiolysin S
Clostridium botulinum A BoNT/A1 ATCC 19397 Firmicutes CLB_0528 clostridiolysin S
Clostridium botulinum A BoNT/A1 Hall Firmicutes CLC_0561 clostridiolysin S
Clostridium botulinum BoNT/B1 Okra Firmicutes CLD_0261 clostridiolysin S
Clostridium botulinum BoNT/A3 Loch Maree Firmicutes CLK_3698 clostridiolysin S
Clostridium botulinum Ba4 str. 657 Firmicutes CLJ_B0564 clostridiolysin S
Clostridium botulinum F230613 Firmicutes CBF_0535 clostridiolysin S
Clostridium botulinum H04402 065 Firmicutes H04402_00508 clostridiolysin S
Clostridium botulinum A ATCC 3502 Firmicutes CBO0487 clostridiolysin S [50]
Clostridiumbotulinum F str. Langeland Firmicutes CLI_0567 clostridiolysin S
Thermoanaerobacter mathranii mathranii A3, DSM 11426 Firmicutes Tmath_0475 **
Brachyspira hyodysenteriae WA1 Spirochaetes BHWA1_02354
Brachyspira pilosicoli 95/1000 Spirochaetes BP951000_0919 *
Brachyspira intermedia PWS/A Spirochaetes Bint_2324 *
Brachyspira murdochii 56–150, DSM 12563 Spirochaetes Bmur_0997 *
*All strains share an identical precursor peptide sequence; **no precursor peptide could be annotated; †Cluster shows similarities to characterized RiPP cluster;
#Cluster was previously detected by genome mining approaches.
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http://www.biomedcentral.com/1471-2164/15/983The C. cellulovorans gene cluster (Figure 7A) encodes a
LAP-like portion, with genes encoding the dehydrogenase
and docking protein of a potential LAP but missing the
cyclodehydratase protein. Furthermore lanthionine modi-
fying proteins and three putative precursor peptides are
located within the cluster, differing slightly in their protein
sequence and showing greater similarity to LAP than to
lanthipeptide precursors (Figure 7B).
Nitrile hydratase-related leader peptides (NHLP)
An intersection between LAP and lanthipeptides is
formed by the class of NHLP (nitrile hydratase-related
leader peptides) and Niff11 (nitrogen-fixing) related RiPPs
[55]. On the one hand representatives of these RiPPs can
contain the cyclodehydratase and dehydrogenase en-
zyme complex of LAP (introduction of heterocycles),
and on the other hand the LanM enzymes involved in
lanthipeptide biosynthesis (see above) [55]. A character-
istic feature of these RiPPs are their precursor peptides,
where NHLP precursors show sequence similarity with
the α-subunit of nitrile hydratases (NHase), but without
the active site motif [55]. The so-called Niff11 precursor
peptides resemble an uncharacterized protein, which can
be frequently found in nitrogen-fixing bacteria (including
cyanobacteria) [55]. Compared to LAP, whose typical
leader peptide sequences are about 24 amino acids in
length, NHLP/Niff11 precursor peptides have much lon-
ger leader sequences, typically in the range of 70–83
amino acids [55]. The leader sequence is often terminated
by a glycine-glycine motif. In contrast to their N-terminal
sequences, the C-terminal ends of NHLP/Niff11 precur-
sors vary considerably between different gene clusters andare rich in cysteine, serine and threonine, which are re-
quired for the posttranslational modifications [55].
The putative anaerobic NHLP/Niff11 clusters are lo-
cated exclusively in the Actinobacteria, δ-Proteobacteria
and Firmicutes phyla and all putative precursor peptides
are annotated as NHLP or Niff11-superfamily proteins.
The leader sequences (taken as the amino acid sequence
before the GG motif ) have a range between 66–85
amino acids, whilst the core sequences, taken as the
amino acid sequence following the conserved VAGG or
VSGG motif, are quite variable in length (14–59 amino
acids) (Table 7, Figure 8B). The number of putative pre-
cursor peptides also differs from one to three depending
on the individual gene cluster (Figure 8A). It is striking
that cyclodehydratase and dehydrogenase related genes
were only observed in the gene clusters present in Syn-
trophomonas wolfei subsp. wolfei str. Goettingen and
Pelotomaculum thermopropionicum (Figure 8A). In the
other cases a transporter with an N-terminal peptidase
was identified, as well as several radical SAM proteins,
which may be responsible for the modification steps of
the NHLP/Niff11 precursors. Furthermore, proteins im-
portant for secretion are also located within several of
the gene clusters (Figure 8A).
Lasso peptides
Lasso peptides are among the most extraordinary RiPPs,
and their rigid structure gives them enormous stability
against heat, chemical attack and proteases [1,56,57]. So
named because of their particular knotted structure, the
lasso peptides are usually 16–23 amino acids in length
and contain an 8–9 membered macrolactam ring, which
Figure 7 Detected putative thiopeptides. A Gene cluster of thiomuracin (tpd) (Nonomuraea str. Bp3714-39) in comparison to putative thiopeptide
gene clusters of C. cellulovorans 743B and P. acnes KPA171202; Numbers represent the locus tag for each gene within the genome sequence of each
organism. B Comparison of precursor peptides of thiomuracin (TpdA) and putative precursor peptides of C. cellulovorans 753B and P. acnes KPA171202;
Cleavage site of leader and core peptide in bold. C Introduction of the central nitrogen heterocycle (red) in series d thiopeptides. D Chemical structure
of thiomuracin A.
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carboxylate of a conserved aspartate or glutamate resi-
due at position 8 or 9, by a putative asparagine synthase
like enzyme, resulting in a C-terminal loop and tail for-
mation [1,56,57] (Figure 9B & C). Three subgroups of
the lasso peptides have been characterized. The proto-
typical members of the group I lasso peptides include
siamycin I [58], siamycin II [58] and RP71955 [59], all of
which possess two disulfide bonds and an N-terminalTable 6 Detected thiopeptide gene cluster
Phylum Locus Tag of
modifying enzyme Lan
Clostridium cellulovorans 743B Firmicutes Clocel_3634
Propionibacterium acnes
KPA171202
Actinobacteria PPA0859cysteine [1,56,57]. In contrast, group II lasso peptides
contain no disulfide bonds, and the N-terminal amino
acid is glycine [1,56,57], with examples in the form of
microcin J25 [60,61], lariatin [62] and capistruin [63,64].
Lasso peptide BI-32169 [65,66] is the only member of
group III, having one disulfide bridge and glycine as the
N-terminal amino acid [1,56,57].
Studies on the biosynthesis of microcin J25 from E.
coli AY25 [67,68] and capistruin from Burkholderia thai-
landensis [63,64] have shown that four genes (‘A-D’) are
necessary for lasso peptide formation. In each case, the
leader sequence is cleaved by an ATP-dependent prote-
ase (‘B’) from the precursor peptide (‘A’), with the simul-
taneous activation of the aspartate or glutamate residues
[1,56,57]. Isopeptide bond formation is catalyzed by an
ATP-dependent enzyme (‘C’), which has similarities to
Table 7 Detected putative NHLP/Niff11-like gene cluster
Phylum Precursor (Leader:Core)+ Gene tag of precursor peptides Reference#
Eggerthellalenta VPI 0255 Actinobacteria 121 (71:50) Elen_2949
122 (71:51) Elen_2953
130 (71:59) Elen_2954
Desulfarculusbaarsii 2st14, DSM 2075 δ- Proteobacteria 111 (71:40) Deba_2490
Syntrophomonas wolfei subsp. wolfei str. Goettingen Firmicutes 102 (82:20) Swol_1792 [55]
Desulfotomaculum acetoxidans DSM 771 Firmicutes 84 (66:18) Dtox_0942
83 (66:17) Dtox_0947
Desulfitobacterium hafniense DCP-2 Firmicutes 80 (66:14)* Dhaf_0108
Desulfitobacterium hafniense Y51 Firmicutes 80 (66:14)* DSY0169
Pelotomaculum thermopropionicum SI Firmicutes 109 (85:24) PTH_2328 [55]
102 (85:17) PTH_2334
+amino acid length of precursor sequence (length of leader peptide : core peptide); *identical sequences; #Cluster was previously detected by genome mining
approaches.
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http://www.biomedcentral.com/1471-2164/15/983asparagine synthetase B, and the resulting product is
transported out of the cell through ‘D’, which also en-
sures immunity of the producer to the mature RiPP
[1,56,57]. Only the first eight N-terminal amino acids
and the second last threonine of the leader sequence are
required for its recognition by the modifying enzymes
[69]. Due to conservation of the ‘B’ and ‘C’ enzymes, as
well as conserved motifs in the precursor sequences,
these can all be used as the basis for genome mining
[24,56,67,70-72].
Previous attempts at genome mining for lasso peptides
identified putative gene clusters within the following an-
aerobe genomes: Spirochaeta smaragdinae DSM 11293,
Syntrophomonas wolfei subsp. wolfei str. Goettingen,
Treponema pallidum, Treponema cuniculi paraluiscuni-
culi A, Pelobacter propionicus DSM 2379, Desulfobacca
acetoxidans DSM 111069 and Geobacter uraniireducens
[71,72]. However, upon closer investigation, several of
these gene clusters were either undetected in the present
study, or lacked the necessary genes encoding the
characteristic lasso peptide modifying enzymes and as
such they were not included in the current analysis. In
the case of Desulfobacca acetoxidans both studies
identified identical gene clusters for putative lasso
peptides, with the only difference being the prediction
of the precursor peptide (Figure 9A (* = precursor
peptide identified in this study, # = precursor peptide
identified by [71])).
The biosynthetic gene clusters for microcin J25 and
lariatin are shown in Figure 9A [73,74]. Unlike micro-
cin J25 and other lasso peptides, lariatins A and B,
produced by Rhodococcus jostii, are formed by a five-
gene cluster, larABCDE. Similar to other lasso pep-
tides, LarA is the precursor peptide which is proc-
essed by LarB, LarC and LarD and then exported by
the transporter LarF [73]. Whilst LarB and LarDappear to have similar functions, the role of LarC re-
mains unclear, although it appears that larC is specific
for Gram-positive bacteria [73]. Indeed, this appeared to
be the case, as all anaerobic strains in which lasso peptide
gene clusters were identified (Table 8) were Gram-positive
and contained larC orthologues (Figure 9A). Interestingly,
additional enzymes, such as a HPr kinase and a sulfotrans-
ferase, were also identified in some gene clusters. The role
that these proteins play in the modification of the precur-
sor peptides is currently unclear, although they may be
involved in previously unidentified lasso peptide modifica-
tions [55].
Lactococcin
Like many other RiPPs, lactococcins possess an N-
terminal leader sequence, which terminates in a glycine-
glycine motif. This motif is an important signal unit for
the respective transporters which secrete the substance
and simultaneously cleave off the leader sequence [75].
Lactococcin 972 is homodimeric RiPP, which is only
encoded by one structural gene [76]. This gene encodes a
91 amino acid precursor peptide of which 25 amino
acids comprise the leader sequence and the remain-
der, the core sequence [76,77]. In addition to the pre-
cursor peptide named LclA the gene cluster encodes
a transporter (LclB) and an additional protein that is
important for immunity (Figure 10A). Lactococcin
972 blocks the incorporation of lipid II, an essential
cell wall building block [77-79].
In almost all propionibacteria a lactococcin 972 like
precursor peptide is present, with the exception of Pro-
pionibacterium acnes ATCC 11828, where it is absent
(Figure 10A). The N-terminal leader sequence of P. acnes
266 includes an additional 23 amino acids in comparison
to the other P. acnes strains. The gene organization in the
P. acnes strains is different to Desulfitobacterium hafniese
Figure 8 Detected putative NHLP/Niff. A Structure of putative NHLP/Niff related gene clusters of D. baarsii 2st14, E. lenta VPI 0255, D. hafniense DCP-2, D. acetoxidans DSM 771, S. wolfei subsp.
wolfei str. Goettingen, P. thermopropionicum SI; Numbers represent the locus tag for each gene within the genome sequence of each organism. B Comparison of the putative precursor peptides


















Figure 9 Detected putative lasso peptides. A Microcin J25 (mcj) (E. coli) and Lariatin (lar) (R. jostii K01-B0171) gene clusters in comparision to
putative lasso peptide gene clusters of G. uraniireducens Rf4, P. propionicus DSM 2379, D. acetoxidans DSM 11069 (* = precursor peptide identified
in this study, # = precursor peptide identified by [71]), B. proteoclasticum B313, D. acetoxidans DSM 771, S. glycolicus DSM 8271 and C. perfringens
str. 13; Annotation of the putative precursor peptide was not conclusively possible in most cases; Numbers represent the locus tag for each gene
within the genome sequence of each organism. B Cleavage of the lariatin precursor peptide by a putative protease (LarD); Isopeptide bond
(green) formation by LarB between the N-terminal amino acid glycine (red) and a glutamate (red) leads to the formation of a 8- membered
macrolactame ring in lariatin. C Lasso peptide structure of lariatin (isopeptide bond (green)).
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Table 8 Detected putative lasso peptides
Phylum Gene tag of asparagine synthase Reference#
Geobacter uraniireducens Rf4 δ- Proteobacteria Gura_1351 [71,72]
Pelobacter propionicus DSM 2379 δ- Proteobacteria Ppro_0050 [71]
Desulfobacca acetoxidans ASRB2, DSM 111069 δ- Proteobacteria Desac_0932 [71,72]
Butyrivibrio proteoclasticum B316 Firmicutes bpr_I2380
Desulfotomaculum acetoxidans DSM 771 Firmicutes Dtox_2340
Dtox_3272
Syntrophobotulus glycolicus FIGlyR, DSM 8271 Firmicutes Sgly_1617
Clostridium perfringens 13 Firmicutes CPE0468
#Cluster was previously detected by genome mining approaches.
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to the characterized lactococcin 972 gene cluster of Lacto-
coccus lactis (Figure 10A).
Lactococcin like genes were detected in 11 genomes,
in particular genes encoding lactococcin 972 and lacto-
coccin A like proteins (Table 9). Unlike lactococcin 972,
lactococcin A (Lactococcus lactis subsp. cremoris, Lacto-
coccus lactis subsp. lactis biovar diacetylactis WM4) is a
linear RiPP with a 75 amino acid precursor, containing a
21 amino acid leader sequence [80,81]. Both lactococcins
have a limited spectrum of activity against various Lacto-
coccus strains and the antimicrobial effect of these pep-
tides is based on the binding of the peptide core to a
mannose-phosphotransferase that is localized in the cell
wall of the target organism, resulting in increased cell wall
permeability [77,80,82]. In lactococcin A biosynthesis, the
precursor peptide LcnA is processed by LcnC, a trans-
porter with N-terminal peptidase, and secreted by LcnD
[81] (Figure 10B). A co-localized self-resistance geneFigure 10 Detected putative lactococcins like RiPPs. A Lactococcin 972
putative lactococcin 972 like gene clusters in D. hafniense Y51, B. longumin
tag for each gene within the genome sequence of each organism. B Lacto
putative lactococcin A-like gene cluster in C. perfringens SM 101; (T = transp
genome sequence of each organism.guarantees immunity to lactococcin A. A homologous
gene cluster to lactococcin A could be detected in C. per-
fringens SM 101, where the cluster is flanked by transpo-
sases (Figure 10B).
Head-to-tail cyclized peptides
As the name head-to-tail (HtT) suggests, these peptides
are cyclized between their N- and C-terminus and range
in size between 30–70 amino acids [1]. As with other
cyclized peptides, they show a higher stability to heat, pH
changes and proteases. These peptides tend to be hydro-
phobic and exert their effects by the formation of pores in
the cell membrane of target organisms [1,83]. The most
famous and best known representative of this group is
enterocin AS-48 (Enterococcus sp.) [84]. Other HtT-like
cyclized peptides are the cyanobactins, amatoxins and
cyclotides but they differ in their size and their biosyn-
thetic origin [1,83]. For example, HtT-cyclized peptides
have no additional amino acids at the C-terminal end,gene cluster (lcl) of L. lactis subsp. lactis in comparison to detected
fantis JCM 1222 and P. acnes KPA171202; Numbers represent the locus
coccin A gene cluster (lcn) of L. lactis subsp. cremoris and detected
osase); Numbers represent the locus tag for each gene within the
Table 9 Detected putative lactococcin-like RiPPs
Phylum AA+ Gene tag of precursor Protein family
Lactococcuslactis subsp. lactis Firmicutes 91 lclA Lactococcin 972 producer
Bifidobacterium longum infantis JCM 1222, ATCC 15697 Actinobacteria 135 Blon_0434 Lactococcin 972
148 Blon_1750 Lactococcin 972
Propionibacterium acnes KPA171202 Actinobacteria 93 PPA_0802* Lactococcin 972
Propionibacterium acnes TypeIA2 P.acn17 Actinobacteria 93 TIA2EST22_04040* Lactococcin 972
Propionibacterium acnes TypeIA2 P.acn31 Actinobacteria 93 TIA2EST36_04010* Lactococcin 972
Propionibacterium acnes TypeIA2 P.acn33 Actinobacteria 93 TIA2EST2_03960* Lactococcin 972
Propionibacterium acnes 266 Actinobacteria 114 PAZ_c08490* Lactococcin 972
Propionibacterium acnes 6609 Actinobacteria 93 TIB1ST10_04145* Lactococcin 972
Desulfitobacterium hafniense Y51 Firmicutes 126 DSY2024 Lactococcin 972
Lactococcus lactis subsp. cremoris Firmicutes 75 uc509_p7031 Lactococcin A producer
Clostridium perfringens SM101 Firmicutes 69 CPR_1081 Lactococcin A
*Identical precursor sequences; +Number of amino acids encoded by precursor gene.
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[1,83]. It is still not completely clear how the C-terminal
carboxyl group is activated, however, a protein containing
a conserved domain of unknown function is present in
most of the identified gene clusters [1,83]. ATP-binding
proteins are also present in the majority of the known
gene clusters, which may also be involved in the activation
of the carboxyl group [1,83]. Because of their presence in
many HtT-cyclized protein gene clusters these genes can
be used for genome mining approaches.
Relatively few HtT-cyclized peptides were identified
amongst the genomes analyzed here. Those that were iden-
tified were found in the phyla Firmicutes and Chloroflexi
(Table 10), with several exhibiting homology to circu-
larin A (Figure 11A), a previously characterized peptide of
Clostridium beijerinckii ATCC 25752 [85,86] (Figure 11C).
The gene order in the Caldicellulosiruptor gene clusters is
identical to each other and the precursor sequences differ
by only a few amino acids (Figure 11B). The putative cir-
cularin A gene cluster of C. perfringens SM 101 is quite
different, however, and it has limited conservation
with the circularin A gene cluster in C. beijerinckiiTable 10 Detected putative head-to-tail cyclized peptides
Phylum
Dehalogenimonas lykanthroporepellens BL-DC-9 Chloroflexi
Chloroflexus aurantiacus J-10-fl Chloroflexi
Eubacterium limosum KIST612 Firmicutes
Caldicellulosiruptor bescii Z-1320, DSM 6725 Firmicutes
Caldicellulosiruptor saccharolyticus, DSM 8903 Firmicutes
Caldicellulosiruptor obsidiansis OB47 Firmicutes
Clostridium perfringens SM101 Firmicutes
*Identical cluster but different putative precursor peptide; †Cluster shows similaritieATCC 25752 and is flanked by numerous transposases
(Figure 11A).
Conclusion
Here we have surveyed the genomes of 211 anaerobic
bacteria for the presence of RiPP biosynthetic gene clus-
ters. As such, we have identified >25% of anaerobes are
capable of producing RiPPs either alone or in conjunc-
tion with other secondary metabolites, such as polyke-
tides or non-ribosomal peptides. As with the possession
of NRPS and PKS gene clusters, the most likely RiPP
producer organisms lie within the phyla Proteobacteria
and Firmicutes. However, in contrast to their NRPS and
PKS biosynthetic potential, which was minimal, anaer-
obic Actinobacteria appear to have a greater propensity
for RiPP production. Interestingly, we found that the
phylum Spirochaetes also contains a number of potential
RiPP producing organisms, something that has not pre-
viously been found. In general, it also appears that non-
pathogenic organisms have a greater potential for RiPP
production, which aligns well with what is known about









s to characterized RiPP cluster.
Figure 11 Detected circularin A-like RiPPs. A Circularin A gene cluster (cir) of C. beijerinckii ATCC 25752 in comparison to putative circularin A
like gene cluster of C. bescii Z-1320 and C. perfringens SM 101; Numbers represent the locus tag for each gene within the genome sequence of
each organism. B Alignment of circularin A precursor sequence (CirA) and circularin A-like precursor sequences of C. bescii Z-1320 (Athe_2617), C.
saccharolyticus DSM 8903 (Csac_0526) and C. perfringens SM 101 (CPR_0761) C Amino acid structure of circularin A.
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different RiPP classes, with the LAPs and lactococcins
appearing to be favored by pathogenic anaerobes, whilst
the other classes are more prominent in non-pathogenic
isolates. Surprisingly, isolates from extreme environments
contain a wide range of different RiPPs, in particular
head-to-tail cyclized peptides and lanthipeptides. Despite
the fact that their environmental niche is already re-
stricted, it appears as though it must still be necessary for
these organisms to have some way to defend themselves
against competitors. In total we identified 81 putative
RiPP clusters of which 43 had not been previously de-
scribed and appear to be unique among known RiPP
biosyntetic gene clusters. Furthermore, we were able to
identify 23 gene clusters with similarities to known
RiPP biosynthetic gene clusters, but that have not been
previously identified in anaerobes and we were able to
confirm a further 15 previously identified RiPP gene
clusters.
Amongst the analyzed genomes, several gene clusters
with good correlation to known RiPPs were identified.
These include a number of potential class II lanthipep-
tides from the phyla Firmicutes and Actinobacteria, withsimilarity to the lichenicidin gene cluster from Bacillus
licheniforme; sactipeptides identified in the phylum Fir-
micutes with similarities to the thuricin CD gene cluster
of B. thuringiensis; head-to-tail cyclized peptides within
the phyla Chloroflexi and Firmicutes with homology to
the circularin A biosynthetic gene cluster from C. beijer-
inckii ATCC 25752; and lactococcin 972-like RiPPs from
the phylum of Actinobacteria. The distribution of similar
gene clusters amongst diverse organisms suggests that
horizontal gene transfer has been active in the distribu-
tion of RiPP gene clusters amongst organisms that share
similar environments.
Despite the fact that several identified gene clusters and
precursor peptides show similarities to previously charac-
terized RiPPs, in many instances the prediction of the final
products remains difficult. Differences in the precursor
peptide sequence between similar RiPP products may have
an impact on the final modified structure of the peptide,
meaning that prediction of RiPP homology between spe-
cies where a similar gene cluster exists is also difficult.
In consideration of the increasing number of multiresis-
tant strains, RiPPs are a promising alternative to classical
antibiotic treatment. This investigation is the first report
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RiPPs and the detected putative RiPPs may represent fu-
ture lead compounds in the fight against multirestistant
pathogens. Nevertheless, the identification of all these po-
tential metabolites remains a challenge for the future and
more methods are needed to connect the detected geno-
types to chemotypes [87].
Methods
Genome sequences
Complete and published genome sequences of 211 anaer-
obic bacteria (Additional file 1: Table S1) were obtained
from the NCBI Refseq and draft genome repository.
Analysis of anaerobe genomes
Genomes were analyzed for the presence of RiPP encod-
ing gene clusters by using the web-based bioinformatic
tools antiSMASH [15,16], Bagel and bactibase [17,18].
Predicted gene clusters from each of the database outputs
were inspected manually and compared using BLAST
searches. Putative gene clusters were classified according
to Arnison et al. [1] (antiSMASH data collected in April/
May 2012; Bagel database data collected in January 2014).
Additional file
Additional file 1: Table S1. Genomes (finished and published) of
anaerobic bacteria analyzed in this study.
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